Demographic and other baseline characteristics | No mechanical prophylaxis | GCS alone | ||
---|---|---|---|---|
N = 100 | N = 101 | |||
Edoxaban | Enoxaparin | Edoxaban | Enoxaparin | |
N = 52 | N = 48 | N = 53 | N = 48 | |
Sex, n (%) | ||||
Male | 11 (21.2) | 9 (18.8) | 8 (15.1) | 9 (18.8) |
Female | 41 (78.8) | 39 (81.3) | 45 (84.9) | 39 (81.3) |
Age, (y) | ||||
Mean ± SD | 70.9 ± 7.9 | 71.7 ± 7.8 | 73.5 ± 6.1 | 73.2 ± 7.0 |
Weight, (kg) | ||||
Mean ± SD | 63.2 ± 10.2 | 64.3 ± 11.9 | 56.8 ± 10.2 | 60.3 ± 10.1 |
CLcr, (mL/min) | ||||
Mean ± SD | 78.3 ± 24.6 | 76.2 ± 26.5 | 71.1 ± 20.1 | 74.9 ± 20.0 |
Duration of surgery, (h:min) | ||||
Mean ± SD | 2:03 ± 0:44 | 1:59 ± 0:35 | 1:42 ± 0:26 | 1:45 ± 0:24 |
Tourniquet use during surgery, n (%) | 50 (96.2) | 46 (95.8) | 42 (79.2) | 38 (79.2) |
Method of anesthesia, n (%) | ||||
General anesthesia | 43 (82.7) | 35 (72.9) | 24 (45.3) | 20 (41.7) |
Epidural anesthesia | 8 (15.4) | 7 (14.6) | 17 (32.1) | 14 (29.2) |
Lumbar anesthesia | 24 (46.2) | 24 (50.0) | 38 (71.7) | 34 (70.8) |
Duration from the end of surgery to the start of anticoagulation, (h:min) | ||||
Mean ± SD | 20:31 ± 2:39 | 30:41 ± 3:26 | 19:43 ± 2:59 | 27:08 ± 2:30 |
Duration from surgery to ambulation (days) | ||||
Mean ± SD | 2.2 ± 0.7 | 2.4 ± 0.8 | 3.6 ± 1.4 | 3.8 ± 2.1 |
Duration of treatment (days) | ||||
Mean ± SD | 12.1 ± 1.6 | 11.6 ± 2.6 | 12.4 ± 1.6 | 12.4 ± 1.7 |
Duration of GCS use (days) | ||||
Mean ± SD | - | - | 9.5 ± 2.7 | 9.6 ± 2.7 |